Cargando…

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy

The recently introduced HCM-AF Risk Calculator allows the prognosis of atrial fibrillation (AF) occurrence in hypertrophic cardiomyopathy (HCM) patients. The aim of this study was to assess the clinical application of the HCM-AF Risk Score in the prediction of the clinical outcomes of Polish patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stec, Maria, Suleja, Agata, Gondko, Daniel, Kuczmik, Wiktoria, Roman, Jakub, Dziadosz, Dominika, Szydło, Krzysztof, Mizia-Stec, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342482/ https://www.ncbi.nlm.nih.gov/pubmed/37445519 http://dx.doi.org/10.3390/jcm12134484

Ejemplares similares

Autoimmune Hepatitis—Challenging Diagnosis
por: Mroskowiak, Aleksandra, et al.
Publicado: (2022)

ARNI in HFrEF—One-Centre Experience in the Era before the 2021 ESC HF Recommendations
por: Niemiec, Rafał, et al.
Publicado: (2022)

Cardiac Amyloidosis-Challenging Diagnosis and Unclear Clinical Picture
por: Kozak, Sylwia, et al.
Publicado: (2021)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model
por: Bhattacharya, Moumita, et al.
Publicado: (2021)

Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
por: Bula, Karolina, et al.
Publicado: (2022)

Inter-Specialty Controversies on the Treatment of Cardiovascular Diseases during Pregnancy: A Questionnaire Study
por: Dziadosz, Dominika, et al.
Publicado: (2022)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
por: Melas, Marilena, et al.
Publicado: (2022)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study
por: Lampert, Rachel, et al.
Publicado: (2023)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study
por: Schoonvelde, Stephan A. C., et al.
Publicado: (2023)

Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by Echocardiogram: A Case Presentation
por: Elsouri, Kawther N, et al.
Publicado: (2023)

Symptomatic and silent atrial fibrillation recurrences after pulmonary vein isolation ablation – usefulness of prolonged 7-day Holter recordings. One-center observation
por: Wita, Marcin, et al.
Publicado: (2019)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
por: Sado, Daniel, et al.
Publicado: (2013)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
por: Réant, Patricia, et al.
Publicado: (2023)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)
por: Wang, Lin, et al.
Publicado: (2021)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death
por: Dass, Sairia, et al.
Publicado: (2012)

The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM
por: Kittleson, Mark D, et al.
Publicado: (2021)

Microvolt T-wave alternans testing is abnormal both in left- and right-sided pathology
por: Mizia-Stec, Katarzyna
Publicado: (2016)

Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM)
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2016)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Hyperintense Brain Lesions in Asymptomatic Low Risk Patients with Paroxysmal Atrial Fibrillation Undergoing Radiofrequency Pulmonary Vein Isolation
por: Wieczorek, Joanna, et al.
Publicado: (2021)

Transcatheter aortic valve implantation in moderate bicuspid aortic valve disease in a patient with end-stage dilated cardiomyopathy – bridge to heart transplantation
por: Mizia-Szubryt, Magdalena, et al.
Publicado: (2021)

Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
por: Montag, J., et al.
Publicado: (2018)

Left atrial function in obese and non-obese patients undergoing percutaneous pulmonary vein isolation
por: Cichoń, Małgorzata, et al.
Publicado: (2018)

Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy
por: Kübler, J., et al.
Publicado: (2021)

Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial
por: Reaney, Matthew, et al.
Publicado: (2022)

Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM): A Study from the ClinGen Cardiomyopathy Variant Curation Expert Panel
por: Morales, Ana, et al.
Publicado: (2021)

Subtle structural abnormalities in genotype positive phenotype ‘negative’ patients with pre-clinical hypertrophic cardiomyopathy (HCM): a blinded, controlled cardiovascular magnetic resonance (CMR) study
por: Deva, Djeven, et al.
Publicado: (2012)

Functional Mitral Regurgitation in Patients with Preserved Ejection Fraction Qualified for Pulmonary Vein Isolation: A Negative Prognostic Factor for Catheter Ablation Efficacy
por: Cichoń, Małgorzata, et al.
Publicado: (2021)

Anterior wall myocardial infarction in a young man caused by spontaneous dissection and hematoma of coronary artery
por: Bochenek, Tomasz, et al.
Publicado: (2019)

Histopathology in HCM
por: Tejado, Beatriz San Millán, et al.
Publicado: (2018)

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias
por: Magnusson, Peter, et al.
Publicado: (2020)

Evaluation of the pharmacotherapeutic impact on contractility recovery in patients with newly diagnosed, acute onset dilated cardiomyopathy
por: Orszulak, Michal, et al.
Publicado: (2023)

The use of iloprost in the treatment of ‘out of proportion’ pulmonary hypertension in chronic obstructive pulmonary disease
por: Lasota, Bartosz, et al.
Publicado: (2013)

Pulmonary artery atresia with ventricular septal defect, segmental pulmonary hypertension, major aortopulmonary collaterals (MAPCAs) and giant MAPCA aneurysm
por: Grabka, Marek, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7mvkn0n1a4pl4948m79mdgqgkh